SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as gold prices reach new all-time highs, fueled by economic uncertainty and speculation around central bank policies. The community is debating whether this rally is sustainable or indicative of a larger global financial shift, with some pointing to potential overbought conditions while others highlight ongoing global demand. Discussions also involve gold's role as a safe haven asset amidst concerns about the dollar and potential market corrections.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending downwards as the community discusses a potential offering and overall sector weakness. Some traders are pointing to the company's fundamentals and CEO stock sales as reasons for concern, while others anticipate a bounce. Discussions revolve around shorting opportunities and potential price targets amidst high volatility in the quantum computing sector.

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

Bitfarms Ltd.

Bitfarms is trending due to a proposed offering of convertible senior notes, sparking mixed reactions within the community. While some express concern over potential dilution, others view it as a strategic move for long-term growth and expansion into AI and high-performance data centers, especially with comparisons to similar moves by sector peers. The community is actively debating the implications of the offering and its effect on the stock's future trajectory.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as the stock is struggling to hold above the $300 support level, leading to community discussions about its correlation to Bitcoin's price movements and potential downside risks. Some traders are expressing frustration with the stock's performance compared to miners and Bitcoin ETFs, while others speculate about potential catalysts like S&P 500 inclusion or a Bitcoin rally. The community is actively debating whether this dip presents a buying opportunity or signals further declines.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors discuss potential trade setups and debate the stock's current valuation relative to its peers and future earnings potential. Community sentiment appears mixed, with some anticipating a breakout while others foresee a pullback, especially with earnings around the corner. Discussions also include Amazon's AI initiatives and their impact on AWS growth.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is experiencing volatility, with community members debating its role as a hedge against traditional assets like gold, which is currently seeing gains. Discussions include potential market manipulation and the impact of external factors such as political announcements and trade tensions. Some traders are anticipating a continued downturn, while others see current levels as a buying opportunity before a potential rebound.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA ($NVDA) is trending amid discussions about its valuation, potential pullbacks, and technical analysis patterns, including head and shoulders formations and Fibonacci levels for intraday trading. Community members are weighing factors like high margin debt, AI bubble concerns, and upcoming earnings, while also keeping an eye on competitor AMD and potential government impacts.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is seeing increased volatility amid concerns about credit quality and regional banks, sparking fears reminiscent of the 2008 financial crisis. Community members are closely watching gold's surge as a potential safe haven and debating the impact of a potential China trade war. Additionally, a highly anticipated announcement added to market uncertainty, with some expressing disappointment over its content.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to volatility following a recent surge, with community discussions focused on potential shareholder dilution from executive stock sales and skepticism about management. Political factors, specifically comments about drug prices, are also impacting sentiment, while some traders see a short squeeze opportunity amidst ongoing debates about the company's long-term prospects after their new menopause offerings.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

Praxis Precision Medicines ($PRAX) is trending due to positive Phase 3 trial results for their essential tremor treatment, leading to significant price movement and analyst upgrades. The community is actively discussing a potential public offering and its impact on the stock's valuation, with some anticipating a drop while others believe the news is already priced in. Short sellers are facing pressure as the stock experiences a squeeze, with institutional ownership playing a significant role in the volatile trading.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of +6.25% and +0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Danaher (DHR) Q2 Earnings and Revenues Top Estimates

Danaher (DHR) delivered earnings and revenue surprises of +9.76% and +1.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners, Inc. (SGRY) on Tuesday announced that it has <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.surgerypartners.com/news-releases/news-release-details/surgery-partners-inc-and-bain-capital-conclude-discussions">decided</a> to reject Bain Capital Private Equity’s proposal to take the healthcare services company private. Following the announcement, SGRY stock slumped 13% by Tuesday morning.Surgery Partners, headquartered in Brentwood, Tennessee, said that the firm’s independent committee determined that the company’s prospects to deliver long-term growth and value creation as an independent publicly traded company exceeded the value of the proposal by Bain Capital, its largest shareholder. &nbsp;Brent Turner, Chairman of the independent committee, said that it believes the best path forward for Surgery Partners is to continue operating as an independent publicly traded company.“We remain confident in the management team’s ability to continue delivering sustained growth and significant stockholder returns,” he said.Bain Capital put forth its proposal to acquire all of the outstanding shares of Surgery Partners not already owned by it for a cash consideration of $25.75 per share in January.Meanwhile, CEO Eric Evans on Tuesday also expressed confidence in the company achieving its full-year 2025 revenue and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance.The company expects to report 2025 revenues in the range of $3.30 billion to $3.45 billion and adjusted EBITDA in the range of $555 million to $565 million for the year.Bain Capital Partners Andrew Kaplan and Devin O’Reilly also said that they remain “tremendously optimistic” about the business despite not being able to agree on the terms of the transaction.<a href="https://stocktwits.com/symbol/SGRY">SGRY stock</a> is down 6% this year and approximately 20% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-agrees-to-acquire-verve-therapeutics-for-up-to-1.3-billion/chlYyFpRRTy">Verve Therapeutics Stock Rockets 75% Pre-Market After Eli Lilly Agrees To Acquire The Company For Up To $1.3B: Retail Says Offer Is ‘Low’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal

Chairman of the Independent Committee, Brent Turner, said the best path forward for Surgery Partners is to continue operating as an independent publicly traded company.

Equity

9 Analysts Assess Surgery Partners: What You Need To Know

Latest Ratings for SGRY
 DateFirmActionFromTo Mar 2022JP MorganMaintainsNeutral Mar 2022SVB LeerinkMaintainsOutperform Mar 2022RBC CapitalMaintainsOutperform
 View More Analyst Ratings for SGRY...

What 8 Analyst Ratings Have To Say About Surgery Partners

Surgery Partners (SGRY) Poised for Upside: A Comprehensive Buy Rating Justification

In a report released on July 18, Whit Mayo from Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY Research Report), with a price...

Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know

While shareholders of Surgery Partners (NASDAQ:SGRY) are in the black over 5 years, those who bought a week ago aren't so fortunate

Surgery Partners, Inc. ( NASDAQ:SGRY ) shareholders might be concerned after seeing the share price drop 13% in the...

Surgery Partners: A Buy Rating Amidst Underperformance and Growth Potential

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY Research Report), retaining the price target of $47.00. W...

Surgery Partners (SGRY, $29.94) Stochastic Oscillator left the overbought zone on March 27, 2024

This is a signal that SGRY's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Surgery Partners Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$21.13
Prev Close	$21.11
Open	$21.14
Dividend Yield	0.00%
50-Day Moving Average	$22.02
Beta	1.41
Avg. Volume	1.34M
PE Ratio	-14.78

52-Week High	$33.37
52-Week Low	$18.87
Market Capitalization	$2.71B
EPS (Annual)	-$1.33
Price to Book	1.55
Revenue Per Employee	$207,620.00
Enterprise Value/EBITDA	N/A

SGRY
Surgery Partners Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SGRY News

SGRYSurgery Partners Inc